When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
EDSA - Edesa on go with study of EB02 for internal hemorrhoids; shares up 27% premarket
Edesa Biotech Inc.
Thinly traded nano cap Edesa Biotech (NASDAQ:EDSA) is up 27% premarket on increased volume in response to Health Canada's sign-off on a clinical trial evaluating topical cream EB02 for the treatment of internal hemorrhoids.
More news on: Edesa Biotech, Inc., Healthcare stocks news, Stocks on the move,